Skip to main content
SpringerLink
Log in

Rapid improvement of severe fatty liver in a case of fulminant type 1 diabetes following insulin treatment

  • Case Report
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

A 36-year-old woman presented to the emergency room with a consciousness disorder after developing abdominal pain with diarrhea for 2 days. She presented with marked hyperglycemia, ketoacidosis, and increased serum free fatty acid (FFA) levels; however, no elevation in the glycated hemoglobin (HbA1c) levels was observed. Based on the marked depletion of insulin secretion, the patient was diagnosed as diabetic ketoacidosis attributed to fulminant type 1 diabetes (FT1D). Computed tomography on admission revealed severe fatty liver (FL), which improved 17 h following insulin treatment. Insulin treatment also suppressed the serum FFA levels. Some cases of FT1D with FL and liver dysfunction have been reported previously; however, its pathogenesis and clinical course remain unclear. Compared to previous reports, this case reported the shortest time for FL improvement. In this case, rapid and severe insulin deficiency led to a markedly high FFA level and significant accumulation of triglycerides in the hepatocytes, resulting in severe FL. A rapid and large dose of insulin was administered when systemic insulin sensitivity was nearly maximal owing to insulin deficiency, increased insulin efficacy, early reduction of FFA, suppressed triglyceride accumulation in the hepatocytes, and increased triglyceride excretion from the liver. All these factors could have contributed to the rapid improvement in FL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

Clinical data from the corresponding author are available upon request.

References

  1. Takaike H, Uchigata Y, Iwamoto Y, Imagawa A, Iwahashi H, Kanatsuka A, Kawakaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Hanafusa T, Makino H. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus. Ann Med. 2008;40(5):395–400.

    Article  CAS  PubMed  Google Scholar 

  2. Takaike H, Uchigata Y, Iwasaki N, Iwamoto Y. Transient elevation of liver transaminase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract. 2004;64:27–32.

    Article  CAS  PubMed  Google Scholar 

  3. Kwong TC, Sparks JD, Cianci JF, Sparks CE. Inhibition of apolipoprotein B net synthesis and secretion from cultured rat hepatocytes by the calcium-channel blocker diltiazem. Europe PMC. 1989;263(2):411–5.

    CAS  Google Scholar 

  4. Sparks JD, Zolfaghari R, Sparks CE, Smith HC, Fisher EA. Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats. J Clin Invest. 1992;89(5):1418–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Eric F, Elizabeth L, Roger SM. Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion. J Biomed Res. 2014;28(3):178–93.

    Article  Google Scholar 

  6. Tamura S, Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1139–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36(3):232–40.

    Article  CAS  PubMed  Google Scholar 

  8. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine. 1996;75(6):327–33.

    Article  CAS  PubMed  Google Scholar 

  9. Sherigar JM, Castro JD, Yin YM, Guss D, Mohanty SR. Glycogenic hepatopathy: a narrative review. World J Hepatol. 2018;10(2):172–85.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Rogal SS, Ukomadu C, Levy BD, Loscalzo J. A sweet source of abdominal pain. N Engl J Med. 2011;364(18):1762–7 (Clinical problem-solving).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge the work of the past and present members of our department.

Author information

Authors and Affiliations

  1. Department of Diabetes and Endocrinology, University of Yamanashi Hospital, 1110 Shimokato, Chuo-shi, Yamanashi, 4093898, Japan

    Sonomi Noda, Nozomi Harai, Saki Komai, Takahiko Inukai, Tomomi Watanabe, Tadatsugu Hosokawa, Airi Antoku, Yuko Muroi, Ryosuke Hayashida, Hideyuki Okuma & Kyoichiro Tsuchiya

  2. Department of Gastroenterology Faculty of Medicine, University of Yamanashi Hospital, 1110 Shimokato, Chuo-shi, Yamanashi, 4093898, Japan

    Yuichiro Suzuki

Authors
  1. Sonomi Noda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nozomi Harai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saki Komai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takahiko Inukai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomomi Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tadatsugu Hosokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Airi Antoku
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yuko Muroi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ryosuke Hayashida
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hideyuki Okuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yuichiro Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kyoichiro Tsuchiya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nozomi Harai.

Ethics declarations

Conflict of interest

The authors state that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noda, S., Harai, N., Komai, S. et al. Rapid improvement of severe fatty liver in a case of fulminant type 1 diabetes following insulin treatment. Diabetol Int 15, 297–301 (2024). https://doi.org/10.1007/s13340-023-00675-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-023-00675-5

Keywords

Search

Navigation